Literature DB >> 26163288

High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis.

Yoshinao Muro1, Kazumitsu Sugiura2, Mizuho Nara3, Izumi Sakamoto4, Noriyuki Suzuki5, Masashi Akiyama2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26163288     DOI： 10.1093/rheumatology/kev247

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

1.  Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.

Authors:  Lisa K Peterson; Troy D Jaskowski; Sonia L La'ulu; Anne E Tebo
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 2.  Triggers of inflammatory myopathy: insights into pathogenesis.

Authors:  Brittany L Adler; Lisa Christopher-Stine
Journal:  Discov Med       Date:  2018-02       Impact factor: 2.970

Review 3.  Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 4.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

5.  Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.

Authors:  Yongpeng Ge; Xin Lu; Xiaoming Shu; Qinglin Peng; Guochun Wang
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

Review 6.  Dermatomyositis autoantibodies: how can we maximize utility?

Authors:  Luqman Mushila Hodgkinson; Tiffany Tingshuen Wu; David Franklin Fiorentino
Journal:  Ann Transl Med       Date:  2021-03

Review 7.  Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.

Authors:  Milena Marzęcka; Anna Niemczyk; Lidia Rudnicka
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-11       Impact factor: 10.817

Review 8.  Idiopathic inflammatory myopathies overlapping with systemic diseases.

Authors:  Sébastien Lepreux; Johannes A Hainfellner; Anne Vital
Journal:  Clin Neuropathol       Date:  2018 Jan/Feb       Impact factor: 1.368

Review 9.  Bench to bedside review of myositis autoantibodies.

Authors:  Boaz Palterer; Gianfranco Vitiello; Alessia Carraresi; Maria Grazia Giudizi; Daniele Cammelli; Paola Parronchi
Journal:  Clin Mol Allergy       Date:  2018-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.